Inhibitory effect of resveratrol on proteinuria, hypoalbuminemia and hyperlipidemia in nephritic rats

Life Sciences

Volumn 68, Issue 25, 2001, Pages 2845-2852

  Nihei, Takeshi ^a   Miura, Yutaka ^a   Yagasaki, Kazumi ^a  

^a TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY   (Japan)

Author keywords

Glomerulonephritis; Hyperlipidemia; Hypoalbuminemia; Proteinuria; Resvertrol

Indexed keywords

ALBUMIN; PROTEIN; RESVERATROL;

ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUCED DISEASE; HEPATOMEGALY; HYPERLIPIDEMIA; HYPOALBUMINEMIA; KIDNEY HYPERTROPHY; MALE; NEPHROTIC SYNDROME; NONHUMAN; PROTEIN URINE LEVEL; PROTEINURIA; RAT; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ALBUMINS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BASEMENT MEMBRANE; BLOOD UREA NITROGEN; BODY WEIGHT; CHOLESTEROL; DISEASE MODELS, ANIMAL; EATING; GLOMERULONEPHRITIS; HYPERLIPIDEMIAS; HYPOPROTEINEMIA; KIDNEY; KIDNEY GLOMERULUS; LIVER; MALE; ORGAN SIZE; PROTEINURIA; RABBITS; RATS; RATS, WISTAR; STILBENES; TRIGLYCERIDES;

EID: 0035843894     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(01)01061-X     Document Type: Article

References (20)

1. Morel-Maroger Striker L, Killen PD, Chi E, Striker GE. The composition of glomerulosclerosis. I. Studies in focal sclerosis, crescentic glomerulonephritis, and membranoproliferative glomerulonephritis. Laboratory Investigation 1984;51(2):181-92.
2. Schnaper HW, Kopp JB, Poncelet AC, Hubchak SC, Stetler-Stevenson WG, Klotman PE, Kleinman HK. Increased expression of extracellular matrix proteins and decreased expression of matrix proteases after serial passage of glomerular mesangial cells. Journal of Cell Science 1996;109 ( Pt 10):2521-8.
3. Moorhead JF, Chan MK, El-Nahas M, Varghese Z. Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 1982;2(8311):1309-11.
4. Kasiske BL, O'Donnell MP, Cleary MP, Keane WF. Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney International 1988;33(3):667-72
5. Suzuki Y, Tsukushi Y, Ito M, Nagamatsu T. Antinephritic effect ofY-19018, a thromboxane A synthetase inhibitor, on crescentic-type anti-GBM nephritis in rats. Japanese Journal of Pharmacology 1987;45(2):177-85.
6. Fujisawa K, Yagasaki K, Funabiki R. Effects of low casein and fish oil on hyperlipidemia and proteinuria in nephritic rats. Lipids 1994;29(11):779-83.
7. Fujisawa K, Yagasaki K, Miura Y, Funabiki R. Improvement of hyperlipidemia and proteinuria without noticeable growth retardation by feeding a methionine and threonine supplemented low-casein diet to nephritic rats. Bioscience, Biotechnology, and Biochemistry 1995;59(10):1896-900.
8. Fujisawa K, Yagasaki K, Funabiki R. Reduction of hyperlipidemia and proteinuria without growth retardation in nephritic rats by a methionine-supplemented, low-soy-protein diet. American Journal of Clinical Nutrition 1995;61(3):603-6.
9. Fujisawa K, Yagasaki K, Funabiki R, Masuda S, Sasaki R. Restoration of low casein feed-induced decrease in serum erythropoietin concentration by fortifying diet with methionine and threonine in normal and nephritic rats. Nutrition Research 2000;20(5):685-93.
10. Fauconneau B, Waffo-Teguo P, Huguet F, Barrier L, Decendit A, Merillon JM. Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Science 1997;61(21):2103-10.
11. Kawada N, Seki S, Inoue M, Kuroki T. Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology 1998;27(5): 1265-74.
12. Rotondo S, Rajtar G, Manarini S, Celardo A, Rotillo D, De Gaetano G, Evangelista V, Cerletti C. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. British Journal of Pharmacology 1998;123(8):1691-9.
13. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997;275(5297):218-20.
14. Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet 1993;341(8852):1103-4.
15. Suzuki Y, Nagamatsu T, Kito T, Kohmura T, Ito M. Pharmacological studies on experimental nephritic rats (11). Changes in pathohistological and biochemical parameters in anti-rat GBM rabbit serum-induced nephritis. Nippon Yakurigaku Zasshi 1981;77(4):407-17.
16. Arichi H, Kimura Y, Okuda H, Baba K, Kozawa M, Arichi S. Effects of stilbene components of the roots of Polygonum cuspidatum Sieb, et Zucc. On lipid metabolism. Chemical and Pharmaceutical Bulletin 1982; 30(5):1766-70.
17. Folch J, Lees M, Sloane-Stanley GH. A simple methd for the isolation and purification of total lipides from animal tissues. Journal of Biological Chemistry 1957;226(1):497-509.
18. Yagasaki K, Okada K, Mochizuki T, Takagi K, Irikura T. Effect of 4-(4′-chlorobenzyloxy)benzyl nicotinate (KCD-232) on triglyceride and fatty acid metabolism in rats. Biochemical Pharmacology 1984;33(20):3151-63.
19. Okada K, Yagasaki K, Mochizuki T, Takagi K, Irikura T. Effect of 4-(4′-chlorobenzyloxy)benzyl nicotinate (KCD-232) on cholesterol metabolism in rats. Biochemical Pharmacology 1985;34(18):3361-7.
20. Wilson T, Knight TJ, Beitz DC, Lewis DS, Engen RL. Resveratrol promotes atherosclerosis in hypercholesterolemic rabbits. Life Sciences 1996;59(1):PL15-21.